Is AI ready to take over your prescriptions? Doctors are wary of Utah’s automated refill program

Source Domain: www.cnn.com

A prescription refill program in Utah utilizing an AI chatbot named Doctronic to handle tasks traditionally performed by human doctors has sparked a significant debate about AI’s role in medicine.
AI in healthcare raises questions about regulation, safety, and whether such technology should be permitted to supersede human doctors in certain medical tasks.
Currently, the AI program is partially automated with initial oversight by human doctors and is operating without federal FDA approval, though it utilizes a “regulatory sandbox” to operate.
Opposition from medical professionals highlights concerns about patient safety, the changing nature of medical practice, and the potential replacement of human jobs with AI.
The debate points to an inconsistency in the existing regulatory frameworks, with state laws delegating oversight to state boards which sometimes conflict with federal oversight by the FDA.
While proponents of AI in healthcare, such as Doctronic’s co-founder, emphasize improving access and efficiency in healthcare, critics argue for stringent regulations mimicking those for human doctors.
The FDA has taken a hands-off approach, emphasizing patient safety but not yet setting standards specifically for AI medical technologies.
In the short term, AI-driven healthcare expansion may occur, but long-term risks include diminishing public trust and regulatory backlash.

You may have missed